Trends in the incidence of oropharyngeal cancers in the United States

Otolaryngology - Head and Neck Surgery (United States)

Volumn 154, Issue 6, 2016, Pages 1034-1040

  Enomoto, Laura M ^a   Bann, Darrin V ^a   Hollenbeak, Christopher S ^a,b   Goldenberg, David ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

HPV; oropharyngeal squamous cell carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; BLACK PERSON; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CAUCASIAN; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OROPHARYNX CARCINOMA; PACIFIC ISLANDER; PAPILLOMAVIRUS INFECTION; RACE DIFFERENCE; SEX DIFFERENCE; TONGUE CARCINOMA; TONSIL CARCINOMA; TREND STUDY; TUMOR RECURRENCE; TUMOR VOLUME; UNITED STATES; CARCINOMA, SQUAMOUS CELL; INCIDENCE; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; REGISTER; VIROLOGY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; REGISTRIES; SEER PROGRAM; UNITED STATES;

EID: 84973467778     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599816633690     Document Type: Article

References (26)

1. Agaku IT, King BA, Dube SR, Centers for Disease Control and Prevention. Current cigarette smoking among adults: United States, 2005-2012. MMWR Morb Mortal Wkly Rep. 2014; 63: 29-34.
2. Chaturvedi AK, Anderson WF, Lortet-Tieulent J, et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol. 2013; 31: 4550-4559.
3. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29: 4294-4301.
4. Morales-Sanchez A, Fuentes-Panana EM,. Human viruses and cancer. Viruses. 2014; 6: 4047-4079.
5. Hernandez BY, Wilkens LR, Zhu X, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis. 2008; 14: 888-894.
6. D'Souza G, Cullen K, Bowie J, Thorpe R, Fakhry C,. Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One. 2014; 9: e86023.
7. Herbenick D, Reece M, Schick V, et al. Sexual behavior in the United States: results from a national probability sample of men and women ages 14-94. J Sex Med. 2010; 7 (suppl 5): 255-265.
8. Sedaghat AR, Zhang Z, Begum S, et al. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope. 2009; 119: 1542-1549.
9. Nygard M, Aagnes B, Bray F, Moller B, Mork J,. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer. Eur J Cancer. 2012; 48: 1341-1346.
10. Dahlstrom KR, Calzada G, Hanby JD, et al. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer. 2013; 119: 81-89.
11. National Cancer Institute. Overview of the SEER Program. http://seer.cancer.gov/about/overview.html. Accessed April, 2014.
12. Giovino GA, Schooley MW, Zhu BP, et al. Surveillance for selected tobacco-use behaviors: United States, 1900-1994. MMWR CDC Surveill Summ. 1994; 43: 1-43.
13. Ryan Camilon P, Stokes WA, Nguyen SA, Lentsch EJ,. The prognostic significance of age in oropharyngeal squamous cell carcinoma. Oral Oncol. 2014; 50: 431-436.
14. Agency for Healthcare Research and Quality. National Healthcare Disparities Report. Rockville, MD: US Department of Health and Human Services; 2014.
15. Settle K, Posner MR, Schumaker LM, et al. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients. Cancer Prev Res (Phila). 2009; 2: 776-781.
16. Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012; 307: 693-703.
17. Widdice L, Ma Y, Jonte J, et al. Concordance and transmission of human papillomavirus within heterosexual couples observed over short intervals. J Infect Dis. 2013; 207: 1286-1294.
18. Fisher JW, Brundage SI,. The challenge of eliminating cervical cancer in the United States: a story of politics, prudishness, and prevention. Women Health. 2009; 49: 246-261.
19. Rajput DV, Tupkari JV,. Early detection of oral cancer: PAP and AgNOR staining in brush biopsies. J Oral Maxillofac Pathol. 2010; 14: 52-58.
20. D'Souza G, Dempsey A,. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med. 2011; 53 (suppl 1): S5-S11.
21. Langevin SM, Michaud DS, Eliot M, et al. Regular dental visits are associated with earlier stage at diagnosis for oral and pharyngeal cancer. Cancer Causes Control. 2012; 23: 1821-1829.
22. Lehtinen M, Dillner J,. Clinical trials of human papillomavirus vaccines and beyond. Nat Rev Clin Oncol. 2013; 10: 400-410.
23. National Center for Immunization and Respiratory Diseases. Vaccines that might be indicated for adults aged 19 years or older based on medical and other indications. http://www.cdc.gov/vaccines/schedules/hcp/imz/adult-conditions-shell.html. Published 18, 2014. Accessed October 26, 2014.
24. Jit M, Brisson M, Portnoy A, Hutubessy R,. Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study. Lancet Glob Health. 2014; 2: e406-e414.
25. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612-619.
26. Combes JD, Chen AA, Franceschi S,. Prevalence of human papillomavirus in cancer of the oropharynx by gender. Cancer Epidemiol Biomarkers Prev. 2014; 23: 2954-2958.